BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17950887)

  • 1. Cancer immunotherapy for the veterinary patient.
    Biller BJ
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1137-49; vii. PubMed ID: 17950887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer vaccines.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1111-9; vi-ii. PubMed ID: 17950885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2010 May; 40(3):507-18. PubMed ID: 20471533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veterinary Oncology Immunotherapies.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):257-277. PubMed ID: 29224713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for canine cancer--is it time to go back to the future?
    Killick DR; Stell AJ; Catchpole B
    J Small Anim Pract; 2015 Apr; 56(4):229-41. PubMed ID: 25704119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Fry TJ; Lankester AC
    Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in veterinary oncology.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):925-39. PubMed ID: 25174908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Immunotherapies.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):881-902. PubMed ID: 31186125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Immunotherapy.
    Bergman PJ
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):441-468. PubMed ID: 38158304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology.
    Marconato L; Buracco P; Aresu L
    Vet J; 2015 Aug; 205(2):238-43. PubMed ID: 25862396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve immunotherapy drugs that could cure cancers.
    Cheever MA
    Immunol Rev; 2008 Apr; 222():357-68. PubMed ID: 18364014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
    Rozková D; Tiserová H; Fucíková J; Last'ovicka J; Podrazil M; Ulcová H; Budínský V; Prausová J; Linke Z; Minárik I; Sedivá A; Spísek R; Bartůnková J
    Clin Immunol; 2009 Apr; 131(1):1-10. PubMed ID: 19201656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic anti-cancer chemotherapy as an emerging concept.
    Haynes NM; van der Most RG; Lake RA; Smyth MJ
    Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
    Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
    Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
    Radfar S; Wang Y; Khong HT
    J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.